2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153), an
apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Angiotensin-converting enzyme and hypertension: a systemic analysis of various ACE inhibitors, their side effects, and bioactive peptides as a putative therapy for …

H Ahmad, H Khan, S Haque, S Ahmad… - Journal of the Renin …, 2023 - journals.sagepub.com
Hypertension is a major risk factor for heart attack, produce atherosclerosis (hardening of the
arteries), congestive heart failure, stroke, kidney infection, blindness, end-stage renal …

Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged≥ 75 years: a randomized clinical trial

JD Williamson, MA Supiano, WB Applegate… - Jama, 2016 - jamanetwork.com
Importance The appropriate treatment target for systolic blood pressure (SBP) in older
patients with hypertension remains uncertain. Objective To evaluate the effects of intensive …

The effect of education based on health belief model on promoting preventive behaviors of hypertensive disease in staff of the Iran University of Medical Sciences

NA Azadi, A Ziapour, JY Lebni, SF Irandoost… - Archives of Public …, 2021 - Springer
Background Hypertension is one of the major causes of many diseases, such as heart
attack, strokes, kidney failure, and many internal disorders. This presentresearch study …

[PDF][PDF] Guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

B Williams, G Mancia, W Spiering, E Agabiti Rosei… - Rev Esp …, 2019 - peroxfarma.com
La tarea de elaboración de GPC incluye la creación de herramientas educativas y
programas de implementación de las recomendaciones. Para su implementación, se …

[HTML][HTML] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised …

B Williams, TM MacDonald, S Morant, DJ Webb… - The Lancet, 2015 - thelancet.com
Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …

2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - … of Hypertension of …, 2019 - taylorfrancis.com
Guidelines summarize and evaluate available evidence with the aim of assisting health
professionals in selecting the best management strategies for an individual patient with a …

Effects of sacubitril/valsartan versus olmesartan on central hemodynamics in the elderly with systolic hypertension: the PARAMETER study

B Williams, JR Cockcroft, K Kario, DH Zappe… - …, 2017 - Am Heart Assoc
Effective treatment of systolic hypertension in elderly patients remains a major therapeutic
challenge. A multicenter, double-blind, randomized controlled trial with sacubitril/valsartan …

Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China

W Li, H Gu, KK Teo, J Bo, Y Wang, J Yang… - Journal of …, 2016 - journals.lww.com
Background: Identification and treatment of hypertension in China remain suboptimal
despite high prevalence of hypertension and increasing incidence of stroke and myocardial …